ttboy, I'm not sure breakout is the desired outcome. I'd like this stock to finish every week a one or two cents up! No roller-coaster, just a good strong hard climb.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%